Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
Sat - Sun: Closed
+ (123) 1800-453-1546
info@example.com

Related Posts

Welcome to MedicalPress a Premium Medical Theme

Products

Anti-Hbe

The Biorex Diagnostics HBeAb One Step Rapid Test Device (Serum/Plasma) is a rapid test to qualitatively detect the presence of HBeAb in serum or plasma without the use of an instrument.

Chronic hepatitis B is a serious, debilitating illness that can cause cirrhosis of the liver, liver cancer and death. Chronic hepatitis B is the main cause of liver cancer and the tenth leading cause of death worldwide, with 400,000,000 people infected with the virus. Every year, one million people worldwide are expected to die from this infection. Most people fight off the infection themselves, but approximately 5-10 percent of those infected with the virus become carriers, and an additional 5-10 percent of those infected each year will progress to chronic liver disease, cirrhosis and possibly liver cancer.

Add to Quote

Description

Product Name CAT.No Size
Anti-Hbe HBEABC20 20T
Anti-Hbe HBEABC40 40T

 

 

Product Description

The Biorex Diagnostics HBeAb One Step Rapid Test Device is a rapid, instrument-free immunochromatographic assay for the qualitative detection of Hepatitis B e Antibody (HBeAb) in human serum or plasma. It provides fast and reliable results for clinical laboratories, hospitals, and blood banks, supporting diagnosis, monitoring, and management of Hepatitis B virus (HBV) infection.

Key Features
• Rapid one-step immunoassay – qualitative detection within minutes
• Compatible with serum or plasma – small sample volume required
• High sensitivity and specificity – reliable identification of HBeAb-positive samples
• Instrument-free – no specialised equipment needed, ideal for point-of-care testing
• Quick and convenient – suitable for clinical laboratories, hospitals, and epidemiological surveys

Benefits
Use of the HBeAb Rapid Test Device enables timely detection of HBeAb, helping assess HBV disease phase, monitor antiviral therapy, and support safe blood transfusion practices. Its rapid, ready-to-use format, reliable performance, and ease of interpretation improve clinical workflow, enhance patient management, and provide a cost-effective solution for HBV screening and monitoring programs.

Additional information

Storage

2-8°C